Antimicrobial agents targeting bacterial cell walls and cell membranes

OIE Revue Scientifique et Technique

Volumn 31, Issue 1, 2012, Pages 43-56

  Bush, K ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Cell membrane; Cell wall; Daptomycin; Fosfomycin; Glycopeptide; Ionophore; Lipopeptide; P lactam; Polymyxin; Vancomycin

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); ENTEROCOCCUS; NEGIBACTERIA; STAPHYLOCOCCUS;

EID: 84864058683     PISSN: 02531933     EISSN: 16080645     Source Type: Journal    
DOI: 10.20506/rst.31.1.2096     Document Type: Article

References (96)

1. Abbassi M.S., Achour W, Touati A. & Ben Hassen A. (2009). - Enterococcus faecium isolated from bone marrow transplant patients in Tunisia: high prevalence of antimicrobial resistance and low pathogenic power. Pathol. Biol., 57 (3), 268-271.
2. Abraham E.P. (1987). - Cephalosporins 1945-1986. Drugs, 34(Suppl. 2), 1-14. (Pubitemid 17154371)
3. Adams M.D., Nickel G.C., Bajaksouzian S., Lavender H., Murthy A R., Jacobs M.R. & Bonomo R.A. (2009). -Resistance to colistin in Acinetobacter baumannii associated with mutations in the RmrAB two-component system. Antimicrob. Agents Chemother, 53 (9), 3628-3634.
4. Al-Sweih N.A., Al-Hubail M.A. & Rotimi VO. (2011). -Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals. J. Chemother, 23 (1), 13-16.
5. Albom WE., Jr., Allen N.E. & Preston D.A. (1991). -Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob. Agents Chemother, 35(11), 2282-2287.
6. Allen N.E., Hobbs J.N. & Alborn WE., Jr. (1987). -Inhibition of peptidoglycan biosynthesis in Gram-positive bacteria by LY146032. Antimicrob. Agents Chemother, 31 (7), 1093-1099. (Pubitemid 17099584)
7. Ambler R.P (1980). - The structure of P-lactamases. Philos. Trans, roy Soc. Land., B, biol. Sci., 289, 321-331.
8. Area R, Reguera G. & Hardisson C. (1997). - Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey J. antimicrob. Chemother., 40 (3), 393-399. (Pubitemid 27437960)
9. Arthur M. & Courvalin R (1993). - Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother, 37 (8), 1563-1571. (Pubitemid 23226362)
10. Bernat B.A. & Armstrong R.N. (2001). - Elementary steps in the acquisition of Mn2+ by the fosfomycin resistance protein (EosA). Biochemistry (Wash.), 40 (42), 12712-12718. (Pubitemid 32979724)
11. Bradford PA., Urban C., Mariano N., Projan SJ., RahalJJ. & Bush K. (1997). - Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC P-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother, 41. 563-569. (Pubitemid 27098404)
12. Brown E.D., Vivas E.I., Walsh C.T & Kolter R. (1995). -MurA (MurZ), the enzyme that catalyzes the first committed step in peptidoglycan biosynthesis, is essential in Escherichia coli. J. Bacterial., 177 (14), 4194-4197.
13. Bush K. (2010). - Alarming P-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr. Op. Microbiol, 13 (5), 558-564.
14. Bush K. & Fisher J.E (2011). - Epidemiological expansion, structural studies, and clinical challenges of new P-lactamases from Gram-negative bacteria. Annu. Rev. Microbiol., 65, 455-478.
15. Bush K. & Jacoby G.A. (2010). - Updated functional classification of P-lactamases. Antimicrob. Agents Chemother, 54, 969-976.
16. Butaye R, Devriese L.A. & Haesebrouck F (2003). -Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on Gram-positive bacteria. Üin. Microbiol. Rev., 16 (2), 175-188. (Pubitemid 36519806)
17. Callaway T.R., Edrington T.S., Rychlik J.L., Genovese KJ., Poole XL, Jung Y.S., Bischoff K.M., Anderson R.C. & Nisbet DJ. (2003). - Ionophores: their use as ruminant growth promotants and impact on food safety Curr Issues Intestinal Microbiol, 4 (2), 43-51. (Pubitemid 37121567)
18. Canton R., Ruiz-Garbajosa R, Chaves R.L. & Johnson A.R (2010). - A potential role for daptomycin in enterococcal infections: what is the evidence? J. antimicrob. Chemother, 65 (6), 1126-1136.
19. Chambers H.E (1999). - Penicillin-binding protein-mediated resistance in pneumococci and staphylococci. J. infect. Dis., 179 (Suppl. 28), 353-359.
20. Courvalin P. (2006). - Vancomycin resistance in Gram-positive cocci. Clin, infect. Dis., 42 (1), S25-34. (Pubitemid 41832062)
21. CuiL, Isii T., Fukuda M., Ochiai T., Neoh H.M., Camargo I.L., Watanabe Y., Shoji M., Hishinuma T. & Hiramatsu K. (2010). - An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrob. Agents Chemother, 54 (12), 5222-5233.
22. Danforth H.D., Ruff M.D., Reid WM. & Miller R.L. (1977). -Anticoccidial activity of salinomycin in battery raised broiler chickens. Poult. Sci., 56 (3), 926-932.
23. Davies T.A., He W, Bush K. & Flamm R.K. (2010). - Affinity of ceftobiprole for peniciUin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin. Antimicrob. Agents Chemother, 54 (10), 4510-4512.
24. Diederen B., van Duijn I., van Belkum A., Willemse P., van Keulen P & Kluytmans J. (2005). - Performance of CHROMagar MRSA medium for detection of methicillin-resistant Staphylococcus aureus. J. din. Microbiol, 43, 1925-1927.
25. Draghi D.C., Benton B.M., Krause K.M., Thomsberry C., Pillar C. & Sahm D.F (2008). - Comparative surveillance study of telavancin activity against recently collected Gram-positive clinical isolates from across the United States. Antimicrob. Agents Chemother, 52 (7), 2383-2388. (Pubitemid 351915666)
26. Drawz S.M. & Bonomo R.A. (2010). - Three decades of beta-lactamase inhibitors. Ciin. Microbiol. Rev., 23 (1), 160-201.
27. Du W, Brown J.R., Sylvester D.R., Huang J., Chalker A.E, So C.Y., Holmes D.J., Payne D.J. & Wallis N.G. (2000). -Two active forms of UDP-N-acetylglucosamine enolpyruvyl transferase in Gram-positive bacteria. J. Bacteriol., 182 (15), 4146-4152. (Pubitemid 30463775)
28. DuemlingWW (1946). - Clinical experiences with penicillin in the Navy. Ann. N.Y. Acad. Set, 48, 201-220.
29. Eking L.S., Rubenstein E.B., Kurtin D., Rolston K.V, Fangtang J., Martin C.G., Raad I.I., Whimbey E.E., Manzullo E. & Bodey G.R (1998). - Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice. Cancer, 83 (12), 2597-2607. (Pubitemid 29019582)
30. Evans M.E., Eeola DJ. & Rapp R.R (1999). - Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant Gram-negative bacteria. Ann. Pharmacother, 33 (9), 960-967. (Pubitemid 29420995)
31. Ealagas M.E., Rafaihdis PI. & Matthaiou D.K. (2010). -Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist. Updat., 13 (4-5), 132-138.
32. Fernandez L., Gooderham WJ., Bains M., McPhee J.B., Wiegand I. & Hancock R.E. (2010). - Adaptive resistance to the 'last hope' antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob. Agents aemother., 54 (8), 3372-3382.
33. Fillgrove K.L., Pakhomova S., Newcomer M.E. & Armstrong R.N. (2003). - Mechanistic diversity of fosfomycin resistance in pathogenic microorganisms. J. Am. Chem. Soc., 125 (51), 15730-15731. (Pubitemid 37553675)
34. Fillgrove K.L., Pakhomova S., Schaab M.R., Newcomer M.E. & Armstrong R.N. (2007). - Structure and mechanism of the genomically encoded fosfomycin resistance protein, FosX, from Listeria monocytogenes. Biochemistry (Wash.), 46 (27), 8110-8120. (Pubitemid 47051646)
35. Friedman L., Alder J.D. & Silverman J.A. (2006). - Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob. Agents Chemother, 50 (6), 2137-2145. (Pubitemid 43807536)
36. Fu W, Yang E, Kang X., Zhang X., Li Y, Xia B. & Jin C. (2007). - First structure of the polymyxin resistance proteins. Biochem. Biophys. Res. Comm., 361 (4), 1033-1037. (Pubitemid 47263458)
37. Georgopapadakou N.H. & Uu FY. (1980). - Penicillin-binding proteins in bacteria. Antimicrob. Agents Chemother, 18, 148-157. (Pubitemid 10039803)
38. Giamarellou H. (2010). - Multidrug-resistant Gram-negative bacteria: how to treat and for how long. Int. J. antimicrob. Agents, 36 (2), S50-54.
39. Grayson M.L, Eliopoulos G.M., Wennersten C.B., Ruoff K.L., De Girolami EC., Ferraro M.J. & Moellering R.C., Jr. (1991). -Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob. Agents Chemother, 35 (11), 2180-2184.
40. Green LJ. & Hall WH. (1961). - Treatment of serious Pseudomonas infections with colistin sulfate. International Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology, Boston.
41. Griffith R.S. (1981). - Introduction to vancomycin. Rev. infect. Dis., 3 (4), 200-204.
42. Gunn J.S., Lim K B., Krueger J., Kim K., Guo L, Hackett M. & Miller S.I. (1998). - PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Molec. Microbiol, 11 (6), 1171-1182. (Pubitemid 28137969)
43. Hansen J.L, Levinsen C., Schmidt A. & Eriksen K.R. (1965). -Toxic effect of polymyxin: experiences with clinical material on 307 patients [in Danish). Ugeskr Laeger, 127 (44), 1411-1414.
44. Hirsch H.A., McCarthy C.G. & Finland M. (1960). -Polymyxin B and colistin: activity, resistance and crossresistance in vitro. Proc. Soc. experim. Biol Med., 103, 338-342.
45. Horii T, Kimura T, Sato K., Shibayama K. & Ohta M. (1999). -Emergence of fosfomycin-resistant isolates of Shiga-like toxin-producing Escherichia coU 026. Antimicrob. Agents aemother., 43 (4), 789-793. (Pubitemid 29165741)
46. Howden B.R, Davies J.K., Johnson RD., Stinear TP & Grayson M.L. (2010). - Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Gin. Microbiol Rev., 23 (1), 99-139.
47. Huovinen P, Huovinen S. & Jacoby G.A. (1988). - Sequence of PSE-2 beta-lactamase. Antimicrob. Agents Chemother, 32, 134-136.
48. Islam K.M., Klein U. & Burch D.G. (2009). - The activity and compatibility of the antibiotic tiamulin with other drugs in poultry medicine: a review. Poult. Sci., 88 (11), 2353-2359.
49. Jacoby G.A. & Bush K. (2011). - P-Lactamase classification and amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant enzymes. Available at: www.laheyorg/Studies (accessed on 28 December 2011).
50. Jaurin B. & Grundstrom T. (1981). - amp C cephalosporinase of Escherichia coh K-12 has a different evolutionary origin from that of P-lactamases of the penicillinase type. Proc. natl Acad. Sci. USA, 78, 4897-4901. (Pubitemid 12225588)
51. Jones T., Yeaman M.R., Sakoulas G., Yang SJ., Proctor R.A., Sahl H G., Schrenzel J., Xiong YQ. & Bayer A.S. (2008). -Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob. Agents Chemother, 52 (1), 269-278.
52. Kahan FM., Kahan J.S., Cassidy RJ. & Kropp H. (1974). -The mechanism of action of fosfomycin (phosphonomycin). Ann. N.Y. Acad. Sci., 235, 364-386.
53. Kelesidis T., Humphries R., Uslan D.Z. & Pegues D.A. (2011). - Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin, infect. Dis., 52 (2), 228-234.
54. Kirby WM.M. (1945). - Bacteriostatic and lytic actions of penicillin on sensitive and resistant staphylococci. J. din. Invest., 24, 165-169.
55. Kobayashi S., Kuzuyama T. & Seto H. (2000). -Characterization of the fomA and fomB gene products from Streptomyces wedmorensis, which confer fosfomycin resistance on Escherichia coli. Antimicrob. Agents Chemother, 44 (3), 647-650. (Pubitemid 30117955)
56. Kwa A., Kasiakou S.K., Tam VH. & Falagas M.E. (2007). -Polymyxin B; similarities to and differences from colistin (polymyxin E). Expert. Rev. anti-infect. Ther, 5 (5), 811-821.
57. Levin A.S., Barone A.A., Penco J., Santos M.V, Marinho I.S., Arruda E.A., Manrique E.I. & Costa S.F (1999). -Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin, infect. Dis., 28 (5), 1008-1011. (Pubitemid 29203530)
58. Ugozzi M., Pittaluga F & Fontana R. (1996). - Modification of penicillin-binding protein 5 associated with high-level ampicillin resistance in Enterococcus faecium. Antimicrob. Agents Chemother, 40 (2), 354-357. (Pubitemid 26049346)
59. Lim L.M., Ly N., Anderson D., Yang J.C., Macander L., Jarkowski A., 3rd, Forrest A., Bulitta J.B. & Tsuji B.T. (2010). - Resurgence of colistin; a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy, 30 (12), 1279-1291.
60. Livermore D.M. (2002). - The impact of carbapenemases on antimicrobial development and therapy Curr Opin. Investig. Drugs, 3 (2), 218-224. (Pubitemid 34456076)
61. Livermore D.M. (2009). - Has the era of untreatable infections arrived? J. antimicrob. Chemother, 64 (Suppl. 1), I29-I36.
62. Llaneza J., Villar CJ., Salas J.A., Suarez J.E., Mendoza M.C. & Hardisson C. (1985). - Plasmid-mediated fosfomycin resistance is due to enzymatic modification of the antibiotic. Antimicrob. Agents Chemother, 28 (1), 163-164. (Pubitemid 15029717)
63. Lunde C.S., Hartouni S.R., Jane J.W., Mammen M., Humphrey PR & Benton B.M. (2009). - Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II. Antimicrob. Agents Chemother, 53 (8), 3375-3383.
64. Massova I. & Mobashery S. (1998). - Kinship and diversification of bacterial penicillin-binding proteins and P-lactamases. Antimicrob. Agents Chemother, 42 (1), 1-17. (Pubitemid 28053319)
65. Mendes R.E., Moet G.J., Janechek M.J. & Jones R.N. (2010). - In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates. Antimicrob. Agents Chemother, 54 (6), 2704-2706.
66. Miller T.W, Chaiet L, Kahan P.M., Foltz E.L., Woodruff H.B., Mata J.M., Hernandez S. & Mochales S. (1969). -Phosphonomycin, a new antibiotic produced by strains of Streptomyces. Science, 166, 122-123.
67. Montero C.I., Stock E & Murray PR. (2008). - Mechanisms of resistance to daptomycin in Enterococcus faecium. Antimicrob. Agents Chemother, 52 (3), 1167-1170. (Pubitemid 351358408)
68. Muthaiyan A., Silverman J.A..Jayaswal R.K. & Wilkinson BJ. (2008). - Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization. Antimicrob. Agents Chemother, 52 (3), 980-990. (Pubitemid 351358377)
69. Nair S.K. & van der Donk D.WA. (2011). - Structure and mechanism of enzymes involved in biosynthesis and breakdown of the phosphonates fosfomycin, dehydrophos, and phosphinothricin. Arch. Biochem. Biophys., 505 (1), 13-21.
70. Nannini E., Murray B.E. & Arias C.A. (2010). - Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus. Curr. Opin. Pharmacol, 10 (5), 516-521.
71. Nichol K.A., Sill M., Laing N.M., Johnson J.L., Hoban DJ. & Zhanel G.G. (2006). - Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North America. Int. J. antimicrob. Agents, 27 (5), 392-396.
72. Norris S.R., Stratton C.W. & Kemodle D.S. (1994). -Production of A and C variants of staphylococcal beta-lactamase by methicillin-resistant strains of Staphylococcus aureus. Antimicrob. Agents Chemother, 38 (7), 1649-1650. (Pubitemid 24203584)
73. Novilla M.N. (1992). - The veterinary importance of the toxic syndrome induced by ionophores. Vet. hum. Toxicol, 34 (1), 66-70.
74. O'Hara K. (1993). - Two different types of fosfomycin resistance in chnical isolates of Klebsiella pneumoniae. FEMS Microbiol Lett., 114 (1), 9-16. (Pubitemid 23342940)
75. Parenti E, Schito G.C. & Courvalin R (2000). - Teicoplanin chemistry and microbiology. J. Chemother, 55, 4.
76. Perichon B. & Courvalin P (2009). - VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother., 53 (11), 4580-4587.
77. Pfeifer Y., Witte W, Holfelder M., Busch J., Nordmann P & Poirel L. (2011). - NDM-1-producing Escherichia coli in Germany Antimicrob. Agents Chemother, 55, 1318-1319.
78. Prakash V, Lewis J.S., 2nd, Herrera M.L, Wickes B.L & Jorgensen J.H. (2009). - Oral and parenteral therapeutic options for outpatient urinary infections caused by Enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases. Antimicrob. Agents Chemother, 53 (3), 1278-1280.
79. Rolinson G.N. & Geddes A.M. (2007). - The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA). Int. J. antimicrob. Agents, 29 (1), 3-8. (Pubitemid 44959773)
80. Rossolini G.M., Mantengoli E., Montagnani E & Pollini S. (2010). - Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents. Curr Op. Microbiol, 13 (5), 582-588.
81. Ryffel C., Kayser EH. & Berger-Bachi B. (1992). - Correlation between regulation of mecA transcription and expression of methicillin resistance in staphylococci. Antimicrob. Agents Chemother, 36 (1), 25-31.
82. Shryock T.R. & Richwine A. (2010). - The interface between veterinary and human antibiotic use. Ann. N.Y. Acad. Sci., 1213, 92-105.
83. Silverman J.A., Mortin L.I., Vanpraagh A.D., Li T. & Alder J. (2005). - Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J. infect. Dis., 191 (12), 2149-2152. (Pubitemid 40800587)
84. Souli M., Galani I., Antoniadou A., Papadomichelakis E., Poulakou G., Panagea T., Vourli S., Zerva L., Armaganidis A., Kanellakopoulou K. & Giamarellou H. (2010). - An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital: molecular characterization, epidemiology, and outcomes. Clin, infect. Dis., 50 (3), 364-373.
85. Suarez J.E. & Mendoza M.C. (1991). - Plasmid-encoded fosfomycin resistance. Antimicrob. Agents Chemother, 35 (5), 791-795.
86. Tenover EC. (2010). - The quest to identify heterogeneously resistant vancomycin-intermediate Staphylococcus aureus strains. Int. J. antimicrob. Agents, 36 (4), 303-306.
87. Torok M.E., Chapman A.L., Lessing M.R, Sanderson E & Seaton R.A. (2010). - Outpatient parenteral antimicrobial therapy: recent developments and future prospects. Curr Opin. investig. Drugs, 11 (8), 929-939.
88. Van Bambeke E, Mingeot-Leclercq M.R, Struelens MJ. & Tulkens PM. (2008). - The bacterial envelope as a target for novel anti-MRSA antibiotics. Trends pharmacol Sci., 29 (3), 124-134.
89. Walsh T.R., Weeks J., Uvermore D.M. & Toleman M.A. (2011). - Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet infect. Dis., 11,355-362.
90. Waxman D.J., Yocum R.R. & Strominger J.L. (1980). -Penicillins and cephalosporins are active site-directed acylating agents: evidence in support of the substrate analogue hypothesis. Philos. Trans, roy. Soc. Lond., B, biol. Sci., 289 (1036), 257-271.
91. Wegener H.C., Aarestrup EM., Jensen L.B., Hammerum A.M. & Bager E (1999). - Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe. Emerg. infect. Dis., 5 (3), 329-335. (Pubitemid 29289446)
92. Wu H.C. & Venkateswaran RS. (1974). - Fosfomycin-resistant mutant of Escherichia coli. Ann. N.Y. Acad. Sci., 235, 587-592.
93. Yang SJ., Nast C.C., Mishra N.N., Yeaman M.R., Fey RD. & Bayer A.S. (2010). - Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibihty phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms. Antimicrob. Agents Chemother, 54 (8), 3079-3085.
94. Yokochi T, Inoue Y, Jiang G.Z., Kato Y, Sugiyama T, Kawai M., Fukada M. & Takahashi K. (1994). - Increased phosphodiesters in lipopolysaccharide prepared from the polymyxin B-resistant isolate of Klebsiella pneumoniae. Microbiol. Immunol., 38 (11), 901-903. (Pubitemid 24353707)
95. Zilhao R. & Courvalin R (1990). - Nucleotide sequence of the FosB gene conferring fosfomycin resistance in Staphylococcus epidermidis. FEMS Microbiol. Lett., 56 (3), 267-272. (Pubitemid 20088762)
96. Zscheck K K. & Murray B.E. (1991). - Nucleotide sequence of the beta-lactamase gene from Enterococcus faecalis HH22 and its similarity to staphylococcal beta-lactamase genes. Antimicrob. Agents Chemother, 35 (9), 1736-1740.